HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitroKOVAR, M; KOVAR, L; SUBR, V et al.Journal of controlled release. 2004, Vol 99, Num 2, pp 301-314, issn 0168-3659, 14 p.Article

HPMA copolymers with pH-controlled release of doxorubicin in vitro cytotoxicity and in vivo antitumor activityULBRICH, K; ETRYCH, T; CHYTIL, P et al.Journal of controlled release. 2003, Vol 87, Num 1-3, pp 33-47, issn 0168-3659, 15 p.Conference Paper

HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemiaST'ASTNY, M; PLOCOVA, D; ETRYCH, T et al.European journal of cancer (1990). 2002, Vol 38, Num 4, pp 602-608, issn 0959-8049Article

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomesRIHOVA, B; ETRYCH, T; PECHAR, M et al.Journal of controlled release. 2001, Vol 74, Num 1-3, pp 225-232, issn 0168-3659Conference Paper

New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targetingCHYTIL, P; ETRYCH, T; KONAK, C et al.Journal of controlled release. 2008, Vol 127, Num 2, pp 121-130, issn 0168-3659, 10 p.Article

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activationULBRICH, K; ETRYCH, T; CHYTIL, P et al.Journal of drug targeting. 2004, Vol 12, Num 8, pp 477-489, issn 1061-186X, 13 p.Article

Differences in the intracellular fate of free and polymer-bound doxorubicinHOVORKA, Ondrej; ST'ASTNY, M; ETRYCH, T et al.Journal of controlled release. 2002, Vol 80, Num 1-3, pp 101-117, issn 0168-3659Article

Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals : In vitro effect of extra drug-free GlyPheLeuGly sequencesRIHOVA, B; STROHALM, J; HOVORKA, O et al.Journal of controlled release. 2008, Vol 127, Num 2, pp 110-120, issn 0168-3659, 11 p.Article

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNACARLISLE, R. C; BRIGGS, S. S; HALE, A. B et al.Gene therapy (Basingstoke). 2006, Vol 13, Num 22, pp 1579-1586, issn 0969-7128, 8 p.Article

Polymeric anticancer drugs with pH-controlled activationULBRICH, K; ETRYCH, T; CHYTIL, P et al.International journal of pharmaceutics. 2004, Vol 277, Num 1-2, pp 63-72, issn 0378-5173, 10 p.Conference Paper

HPMA copolymer-bound doxombicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemiaKOVAR, M; MRKVAN, T; STROHALM, J et al.Journal of controlled release. 2003, Vol 92, Num 3, pp 315-330, issn 0168-3659, 16 p.Article